These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9227671)

  • 81. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
    Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Who should receive antidepressants: suggestions from placebo treatment.
    Khan A; Brown WA
    Psychopharmacol Bull; 1991; 27(3):271-4. PubMed ID: 1775597
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients.
    Reynolds CF; Frank E; Kupfer DJ; Thase ME; Perel JM; Mazumdar S; Houck PR
    Am J Psychiatry; 1996 Oct; 153(10):1288-92. PubMed ID: 8831436
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pain predicts longer time to remission during treatment of recurrent depression.
    Karp JF; Scott J; Houck P; Reynolds CF; Kupfer DJ; Frank E
    J Clin Psychiatry; 2005 May; 66(5):591-7. PubMed ID: 15889945
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Personality characteristics as a prognostic factor in using antidepressive drugs in endogenous depression].
    Habrat E; Walecka W
    Psychiatr Pol; 1991; 25(3-4):105-10. PubMed ID: 1821969
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.
    Bech P; Allerup P; Reisby N; Gram LF
    Psychopharmacology (Berl); 1984; 84(2):276-81. PubMed ID: 6438690
    [TBL] [Abstract][Full Text] [Related]  

  • 87. New issues in the prediction of antidepressant response.
    Kocsis JH
    Psychopharmacol Bull; 1990; 26(1):49-53. PubMed ID: 2196626
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Depression.
    Choe CJ; Emslie GJ; Mayes TL
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):807-29. PubMed ID: 23040903
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Status of clinical experiments with the thymoleptic-anxiolytic, dimethacrine].
    Sausgruber H
    Arzneimittelforschung; 1972 Aug; 22(8):1390-9. PubMed ID: 4564744
    [No Abstract]   [Full Text] [Related]  

  • 90. Combining psychotherapy and antidepressants in the treatment of depression.
    de Jonghe F; Kool S; van Aalst G; Dekker J; Peen J
    J Affect Disord; 2001 May; 64(2-3):217-29. PubMed ID: 11313088
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Outpatient treatment of neurotic depression: medication and group psychotherapy.
    Lipman RS; Covi L
    Proc Annu Meet Am Psychopathol Assoc; 1976; (64):178-218. PubMed ID: 772673
    [No Abstract]   [Full Text] [Related]  

  • 92. Multihospital controlled comparison of the therapeutic effects of four antidepressants.
    Act Nerv Super (Praha); 1971; 13(3):166-7. PubMed ID: 4939827
    [No Abstract]   [Full Text] [Related]  

  • 93. The missing link between clinical endpoints and drug targets in depression.
    Della Pasqua O; Santen GW; Danhof M
    Trends Pharmacol Sci; 2010 Apr; 31(4):144-52. PubMed ID: 20117847
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence.
    Conte HR; Plutchik R; Wild KV; Karasu TB
    Arch Gen Psychiatry; 1986 May; 43(5):471-9. PubMed ID: 3516110
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Understanding the use of behavioral rating scales in studies evaluating the efficacy of antianxiety and antidepressant drugs.
    Fankhauser MP; German ML
    Am J Hosp Pharm; 1987 Sep; 44(9):2087-100. PubMed ID: 2890299
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Duration of antidepressant drug treatment. What is an adequate trial?
    Quitkin FM; Rabkin JG; Ross D; McGrath PJ
    Arch Gen Psychiatry; 1984 Mar; 41(3):238-45. PubMed ID: 6367689
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluating and monitoring treatment response in depression using measurement-based assessment and rating scales.
    Trivedi MH
    J Clin Psychiatry; 2013 Jul; 74(7):e14. PubMed ID: 23945456
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Improving treatment of late life depression in primary care: a randomized clinical trial.
    Callahan CM; Hendrie HC; Dittus RS; Brater DC; Hui SL; Tierney WM
    J Am Geriatr Soc; 1994 Aug; 42(8):839-46. PubMed ID: 8046193
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Why the Hamilton Depression Rating Scale endures.
    Bech P; Engelhardt N; Evans KR; Gibertini M; Kalali AH; Kobak KA; Lipsitz JD; Williams JB; Pearson JD; Rothman M
    Am J Psychiatry; 2005 Dec; 162(12):2396; author reply 2397-8. PubMed ID: 16330618
    [No Abstract]   [Full Text] [Related]  

  • 100. [Semiological and psychological predictive factors of response to antidepressive agents].
    Bougerol T
    Encephale; 1991 Dec; 17 Spec No 3():377-86. PubMed ID: 1807962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.